Transmissible drug resistance in certain enteric bacilli isolated in Tehran

Chemotherapy
|January 1, 1981
PubMed

Insights

Antimicrobial resistance is high in gram-negative enteric bacilli from urinary tract infections. Transmissible R factors, mediating drug resistance, were found in many resistant strains of Escherichia coli, Klebsiella pneumoniae, and Proteus species.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Urinary tract infections (UTIs) are commonly caused by gram-negative enteric bacilli.
  • Antimicrobial resistance in these bacteria poses a significant public health challenge.
  • R factors, or resistance plasmids, are a major mechanism for the spread of antimicrobial resistance.

Purpose of the Study:

  • To investigate the prevalence of antimicrobial resistance in gram-negative enteric bacilli from UTIs and normal fecal flora.
  • To determine the presence and frequency of transmissible R factors in resistant bacterial isolates.
  • To compare drug resistance patterns between clinical and healthy isolates of Escherichia coli.

Main Methods:

  • Collected 284 isolates of gram-negative enteric bacilli from UTI patients and healthy individuals.
  • Tested isolates for resistance to various antimicrobial agents.
  • Assessed the presence of transmissible R factors in resistant strains using bacterial conjugation experiments.

Main Results:

  • Klebsiella pneumoniae and Proteus species showed the highest antimicrobial resistance frequencies.
  • Clinical Escherichia coli isolates exhibited significantly higher drug resistance than those from healthy individuals.
  • Transmissible R factors were detected in 43% of resistant E. coli from UTIs and 21-26% from healthy individuals. R factor transfer rates were 26% for K. pneumoniae and 28% for Proteus.

Conclusions:

  • Gram-negative enteric bacilli, particularly from UTIs, demonstrate substantial antimicrobial resistance.
  • Transmissible R factors are prevalent in resistant strains of E. coli, K. pneumoniae, and Proteus, facilitating resistance spread.
  • The high incidence of resistance and R factors highlights the need for strategies to combat antimicrobial resistance in clinical settings.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...